Efficacy of the implantable cardioverter-defibrillator for the prevention of sudden death in hypertrophic cardiomyopathy

被引：0
|
作者：
Maron, BJ
Shen, WK
Link, MS
Epstein, AE
Almquist, AK
Daubert, JP
Bardy, GH
Rea, RF
Favale, S
Boriani, G
Estes, NAM
Spirito, P
机构：
[1] Minneapolis Heart Inst Fdn, Minneapolis, MN USA
[2] Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA
[3] Tufts Univ, New England Med Ctr, Sch Med, Boston, MA 02111 USA
[4] Univ Alabama, Birmingham, AL USA
[5] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[6] Univ Washington, Med Ctr, Seattle, WA 98195 USA
[7] Univ Bologna, Bologna, Italy
[8] Univ Bari, Bari, Italy
[9] Osped Galliera, Genoa, Italy
来源：
CIRCULATION | 1999年 / 100卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3383
引用
收藏
页码：642 / 642
页数：1
相关论文
共 50 条
  • [1] Long-term efficacy of implantable cardioverter-defibrillator for primary and secondary prevention of sudden death in hypertrophic cardiomyopathy
    Manovel Sanchez, A. J.
    Pedrote Martinez, A.
    Arana Rueda, E.
    Garcia-Riesco, L.
    Aranda Dios, A.
    Jimenez Diaz, J.
    Nevado Portero, J.
    Perez De La Yglesia, R.
    Sanchez Brotons, J.
    Errazquin Saenz de Tejada, F.
    [J]. EUROPEAN HEART JOURNAL, 2007, 28 : 476 - 476
  • [2] Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator
    Maron, BJ
    [J]. EUROPEAN HEART JOURNAL, 2000, 21 (24) : 1979 - 1983
  • [3] Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator
    Maron, Barry J.
    Rowin, Ethan J.
    Maron, Martin S.
    [J]. HEART RHYTHM, 2021, 18 (06) : 1012 - 1023
  • [4] Hypertrophic cardiomyopathy and the implantable cardioverter-defibrillator
    Manovel-Sanchez, Ana J.
    Pedrote-Martinez, Alonso
    Arana-Rueda, Eduardo
    de Tejada, Francisco Errazquin-Saenz
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2007, 60 (07): : 784 - 784
  • [5] Prevention of sudden cardiac death by the implantable cardioverter-defibrillator
    Hindricks, Gerhard
    Lenarczyk, Radoslaw
    Kalarus, Zbigniew
    Doering, Michael
    Shamloo, Alireza Sepehri
    Dagres, Nikolaos
    [J]. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2018, 128 (12): : 764 - 770
  • [6] Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy
    Begley, DA
    Mohiddin, SA
    Tripodi, D
    Winkler, JB
    Fananapazir, L
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2003, 26 (09): : 1887 - 1896
  • [7] Implantable Cardioverter-Defibrillator Therapy for Primary Prevention of Sudden Death After Alcohol Septal Ablation of Hypertrophic Cardiomyopathy
    Cuoco, Frank A.
    Spencer, William H., III
    Fernandes, Valerian L.
    Nielsen, Christopher D.
    Nagueh, Sherif
    Sturdivant, J. Lacy
    Leman, Robert B.
    Wharton, J. Marcus
    Gold, Michael R.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (21) : 1718 - 1723
  • [8] Prevention of Sudden Cardiac Death with the Implantable Cardioverter-defibrillator in Children and Adolescents with Hypertrophic Cardiomyopathy: An International Multicenter Study
    Maron, Barry
    Spirito, Paolo
    Ackerman, Michael
    Casey, Susan
    Semsarian, Christopher
    Estes, N. A. Mark
    Day, Sharlene
    Formisano, Francesco
    Bos, J. Martijn
    Maron, Martin
    Link, Mark
    [J]. CIRCULATION, 2012, 126 (21)
  • [9] Prevention of sudden cardiac death: The role of the implantable cardioverter-defibrillator
    Sinha, SK
    Mehta, D
    Gomes, JA
    [J]. MOUNT SINAI JOURNAL OF MEDICINE, 2005, 72 (01): : 1 - 9
  • [10] The role of the implantable cardioverter-defibrillator for prevention of sudden cardiac death
    Josephson, ME
    Callans, DJ
    Buxton, AE
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 133 (11) : 901 - 910
12345